Skip to main content
Top
Published in: The journal of nutrition, health & aging 10/2020

01-12-2020 | Sarcopenia

Effectiveness of a Short-Term Mixed Exercise Program for Treating Sarcopenia in Hospitalized Patients Aged 80 Years and Older: A Prospective Clinical Trial

Authors: R. Wang, Y. Liang, J. Jiang, M. Chen, L. Li, H. Yang, L. Tan, Ming Yang

Published in: The journal of nutrition, health & aging | Issue 10/2020

Login to get access

Abstract

Objectives

To assess the effectiveness of short-term exercise for treating sarcopenia in hospitalized older patients aged 80 years and over.

Design

Prospective clinical trial.

Setting

A post-acute care unit.

Participants

Sarcopenic patients aged 80 years or over.

Interventions

The participants were allocated to the intervention group (to receive a mixed exercise program with 10 sessions over two weeks) or the control group (usual care) based on the sequence of admission.

Outcomes

The primary outcome was the improvement in activities of daily living (ADL) estimated by the change in Barthel Index (BI) score from the baseline to the end of the 2-week intervention. The secondary outcomes were the changes in gait speed, handgrip strength, the time “UP & GO” test (TUG) score, and the Short Physical Performance Battery (SPPB) score.

Results

We included 121 participants (intervention group: n = 62; control group: n = 59). All participants in the intervention group finished all 10 exercise sessions. After the 2-week intervention, patients in the mixed exercise group achieved a significant improvement in ADL compared with their counterparts in the control group (the adjusted mean difference of the change in BI score was 7.8 points, 95% confidence interval (CI) 4.0 to 11.8 points). The mixed exercise program significantly but slightly improved gait speed (adjusted group difference in mean change: 0.06 m/s, 95% CI 0.02 to 0.11 m/s). However, the mixed exercise program did not significantly improve the handgrip strength, SPPB score, or TUG score compared with usual care.

Conclusion

Very old inpatients with sarcopenia can benefit from a mixed exercise program (even as short as two weeks) by improving their ADL and gait speed. However, the long-term effects of exercise on important clinical outcomes need to be further evaluated.
Literature
1.
go back to reference Cruz-Jentoft, A. J. et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 2019;48, 16–31.CrossRefPubMed Cruz-Jentoft, A. J. et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 2019;48, 16–31.CrossRefPubMed
11.
14.
go back to reference Vellas, B. et al. Overview of the MNA—Its history and challenges. J Nutr Health Aging 2006; 10, 456–463.PubMed Vellas, B. et al. Overview of the MNA—Its history and challenges. J Nutr Health Aging 2006; 10, 456–463.PubMed
17.
go back to reference China”, G. A. o. S. o. Chinese National Physical Fitness Evaluation Standard (CNPFES). 15 (People’s Sports Press, 2003). China”, G. A. o. S. o. Chinese National Physical Fitness Evaluation Standard (CNPFES). 15 (People’s Sports Press, 2003).
Metadata
Title
Effectiveness of a Short-Term Mixed Exercise Program for Treating Sarcopenia in Hospitalized Patients Aged 80 Years and Older: A Prospective Clinical Trial
Authors
R. Wang
Y. Liang
J. Jiang
M. Chen
L. Li
H. Yang
L. Tan
Ming Yang
Publication date
01-12-2020
Publisher
Springer Paris
Keywords
Sarcopenia
Care
Published in
The journal of nutrition, health & aging / Issue 10/2020
Print ISSN: 1279-7707
Electronic ISSN: 1760-4788
DOI
https://doi.org/10.1007/s12603-020-1429-x

Other articles of this Issue 10/2020

The journal of nutrition, health & aging 10/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.